For the Chinese people to make a good medicine to eat 8 academicians into Yuhang "the pulse" of bio-pharmaceutical enterprises

Yuhang Bio
Medicine High-tech Park recently welcomed the China Academy of Engineering Medical and Health Department of 8 academicians , they go deep into enterprises, carry out research talks, point to the park construction, for the development of the park enterprises to ask the pulse Yuhang Bio
Pharmaceutical High-tech Industrial Park is the only provincial biopharmaceutical high-tech park in Zhejiang Province, with a total planning area of 20.76 square kilometers By the end of 2014, there were 25 biopharmaceutical enterprises in the park, including Minsheng Pharmaceuticals, Sanofi Minsheng, Tianyuan Bio, Apricot Hui Tianli and a number of well-known enterprises In 2014, the biopharmaceutical industry achieved a production value of 4,001 million yuan, an increase of 20.79 percent year-on-year "Bayda Pharmaceuticals" is a star enterprise in the biopharmaceutical park, the company's chairman, the national "thousand-person plan" winner Ding Clearing said that by Sun Yan
academician led the development of the company's core products - Camina listed nearly 4 years, more than 50,000 cancer patients across the country have used the product And in order to help more patients can take the drug, the company jointly china Pharmaceutical Innovation Promotion Association launched the "Kamena follow-up free drug program." As of June this year, nearly 20,000 patients with advanced lung cancer in China have received free medication, and the value of the drug has exceeded 2 billion yuan, greatly reducing the burden on patients Speaking of the price of cancer drugs, "expensive" is the people
but also the feelings of academicians Yang Baofeng, director of the Department of Medical and Health Sciences and president of Harbin Medical University, made special mention of the price of anti-tumor drugs at the symposium, and reducing prices and improving drug efficiency is The expectation of President Yang for pharmaceutical companies President Yang suggested that experts from Beida Pharmaceutical Organization study the Kamena drug resistance mechanism to break through the bottleneck of drug resistance and further develop to high efficiency and long-term effectiveness "
It is our long-term goal to for the Chinese people to do more good medicines to eat Ding said In addition to Cammena, in March this year, The company's new drug BPI-9016M, a new class 1.1 chemical, was approved for clinical trials of the drug; the company partnered with Amgen in 2013 to introduce its new drug, Patomu Mono, to China, which treats colon cancer; and last October, the company successfully injected $20 million into the U.S Company to jointly develop a new generation of lung cancer-resistant X-396, which will benefit the world as soon as possible Academician Wang Weiqi is an expert in medical electronics in China, and he put forward the idea of drawing on the experience, science and technology and industry of China Medical City to develop precision medical instruments in Yuhang Other expert academicians and so on have put forward practical suggestions for the internationalization research of Yuhang Biopharmaceutical High-tech Park and the construction of academician expert workstation On the same day, Yuhang also held a "ask the plan, administration and service" academician synopsis and "beautiful healthy China" "Internet and trauma treatment" academic report, with the help of academicians' high-end intellectual resources, for Yuhang economic and social transformation and upgrading to provide "think tank" support.